|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | C07K 16/24 | |
| C12N 15/13 | |||
| C12N 15/85 | |||
| C12N 5/10 | |||
| A61K 39/395 | |||
| A61P 19/02 | |||
| A61P 37/00 | |||
| A61P 25/00 |
| (11) | Patento numeris | 1590369 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 04703964.9 |
| Europos patento paraiškos padavimo data | 2004-01-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2005-11-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-03-16 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2004/000019 |
| Data | 2004-01-21 |
| (87) | Numeris | WO 2004/067568 |
| Data | 2004-08-12 |
| (30) | Numeris | Data | Šalis |
| 442798 P | 2003-01-24 | US |
| (72) |
DICKINSON, Craig, Duane, US
VASSEROT, Alain, Philippe, US
WATKINS, Jeffry, Dean, US
LU, Jirong, US
|
| (73) |
Applied Molecular Evolution, Inc.,
3520 Dunhill Street, San Diego, CA 92121,
US
|
| (54) | HUMAN IL-1 BETA ANTAGONISTS |
| HUMAN IL-1 BETA ANTAGONISTS |